Loading…
← CockpitCompetitor Analysis › 002044.SZ Meinian Onehealth Healthcare Holdings Co Ltd Class AOpen in the cockpit ↗

Meinian Onehealth Healthcare Holdings Co Ltd Class A002044.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical/Nursing Services

China's largest private physical-examination (health check-up) chain, serving individual and corporate clients.

≈ A Chinese Concentra-style preventive health check-up chainMomentum strong 60
Mkt cap
$2.60B
US dollars, full cap
Free float
75%
of shares outstanding
$/day
$76.4M
20-day average traded
Fwd P/E
49.6×
forward earnings
ROIC−WACC
+1.5 pp
WACC 8.4%
Hurdle
-1 pp
Req g minus delivered
Next earnings
148 days
15 Apr 2027
Close · CNYCN¥4.57
1D-1.9%
1W-7.5%
1M-6.5%
3M-10.4%
6M-26.6%
YTD-13.4%
1Y-18.1%
ATR %4.0%
52w lowhigh48.5% off high

What Meinian Onehealth Healthcare does

China's largest private physical-examination (health check-up) chain, serving individual and corporate clients.

Sells check-up packages, many of them booked by employers for staff, with individuals paying directly for the rest, so revenue follows the number of exams and add-on tests sold. It runs a mix of owned and partner centers.

In one line: A Chinese Concentra-style preventive health check-up chain.

Products and services

  • Health check-up services
  • Corporate wellness programs
  • Chronic-disease screening add-ons

Customers

  • Individual consumers
  • Corporate clients (employee check-ups)

Where it sits in the supply chain

  • Health Care
  • Healthcare services
  • Physical examination / preventive…

What could go right

  • China preventive-healthcare spending growth

What could go wrong

  • Consumer discretionary spending sensitivity
  • Franchise/branch quality control

Moat: narrow (scale, brand, distribution). Largest branch network gives scale and brand recognition in a fragmented market.

Headquarters: Hangzhou, Zhejiang, China · Employees: 33,119

Named competitors

  • iKang Healthcare private or unlisted

Meinian Onehealth Healthcare at a glance

Size Meinian Onehealth Healthcare (002044.SZ) is a China Health Care company (Medical/Nursing Services) with a market value of $2.60B, the 912th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥4.57 on 18 Nov 2026.

Performance Over six months the shares fell 26.6%, against +19.1% for the median peer and -20.0% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.

Growth Revenue fell 4.5% over the last twelve months (peer median +11.5%); the operating margin is 8.8% (peer median 8.2%).

Valuation It trades at 49.6× forward earnings against a peer median of 37.6× (8th most expensive of 17).

Price implies For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is -1 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.5 points above its cost of capital (8.4% WACC).

Next results Next results expected around 15 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026Peer median 120002044.SZ 75
Six months, rebased to 100: Meinian Onehealth Healthcare against the median of its 20 peers (local-currency closes).

Meinian Onehealth Healthcare financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥10.0BCN¥10.4BCN¥10.7BCN¥10.9BCN¥8.61B
Revenue growth—-3%-2%+26%—
Gross profitCN¥5.11BCN¥4.23BCN¥4.53BCN¥4.61BCN¥2.90B
EBITDAn/aCN¥2.24BCN¥2.31BCN¥2.58BCN¥1.28B
Net incomeCN¥330MCN¥285MCN¥282MCN¥506M-CN¥559M
Free cash flowCN¥1.39BCN¥1.42BCN¥1.23BCN¥1.63BCN¥1.15B
Capital expenditureCN¥496MCN¥419MCN¥446MCN¥408MCN¥425M
Total debtCN¥6.06BCN¥6.67BCN¥6.85BCN¥6.25BCN¥5.81B

Quarterly statements and history in the cockpit →

Meinian Onehealth Healthcare competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%-20%0%+20%MDAVAHADUSALIF-BAZTANEOACHCLALPATHLABAGARWALEYE603882EMEISMCOV-B300244HIMSVIJAYAPSNLSNDAAMBEAWGSBLLN002044.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Meinian Onehealth Healthcare is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%50×100×MDAVAHADUSALIF-BAZTANEOACHCLALPATHLABAGARWALEYE603882300244VIJAYABLLN002044.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Meinian Onehealth Healthcare is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%25%50%75%MDAVAHADUSALIF-BAZTALALPATHLABAGARWALEYE603882EMEISMCOV-B300244VIJAYABLLN002044.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Meinian Onehealth Healthcare is the large dot.

Meinian Onehealth Healthcare competitors and peer comparison

How Meinian Onehealth Healthcare compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Meinian Onehealth Healthcare against its 20 peers (data as of 18 Nov 2026)
Measure002044.SZPeer medianRank in peer set
1-month return-6.5%-3.4%8th lowest of 21
6-month return-26.6%+19.1%2nd lowest of 21
Distance from 52-week high-48.5%-14.8%3rd lowest of 21
Revenue growth (TTM)-4.5%+11.5%2nd lowest of 21
Operating margin8.8%8.2%9th highest of 21
Forward P/E49.6×37.6×8th most expensive of 17
Growth the price implies (Req g, 7 yrs)4.2%20.4%5th least demanding of 15
Growth delivered (Del g)+5.7%+11.0%5th lowest of 15
Hurdle (Req g minus delivered)-1.5 pp+3.9 pp6th least demanding of 15
ROIC minus cost of capital+1.5 pp-1.6 pp8th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Meinian Onehealth Healthcare 002044.SZChina$2.60B-27%-4%9%49.6×4.2%+5.7%
Pediatrix Medical MDUnited States$2.41B+37%+2%12%12.4×-4.4%+2.0%
Aveanna Healthcare AVAHUnited States$2.37B+41%+17%12%12.2×7.7%+10.2%
Addus HomeCare ADUSUnited States$2.25B+29%+12%11%16.2×4.0%+13.2%
AddLife ALIF-B.STSweden$2.13B+15%+2%8%39.0×21.1%+14.6%
Azenta AZTAUnited States$2.03B+162%+5%-2%83.2×38.0%+3.9%
NeoGenomics NEOUnited States$1.98B+72%+11%-6%53.5×n/an/a
Acadia Healthcare ACHCUnited States$3.49B+56%+4%10%18.6×n/an/a
Dr. Lal PathLabs LALPATHLAB.NSIndia$3.53B+15%+17%24%50.5×32.3%+11.8%
Dr. Agarwal's Health Care AGARWALEYE.NSIndia$1.86B+20%+26%15%77.1×43.0%+26.9%
Guangzhou Kingmed Diagnostics 603882.SSChina$1.86B+5%-3%7%29.9×5.4%-6.1%
Emeis EMEIS.PAFrance$1.78B-33%+4%3%n/a21.2%+8.5%
Medicover MCOV-B.STSweden$3.87B+21%+3%7%36.1×19.6%+20.2%
Dian Diagnostics 300244.SZChina$1.70B+1%-5%9%21.8×0.3%-1.1%
Hims & Hers Health HIMSUnited States$4.00B-26%+30%-1%n/an/an/a
Vijaya Diagnostic Centre VIJAYA.NSIndia$1.69B+18%+24%32%63.0×40.4%+16.7%
Personalis PSNLUnited States$1.62B+88%+17%-157%n/an/an/a
Sonida Senior Living SNDAUnited States$1.59B-11%+70%-8%n/an/an/a
Ambea AMBEA.STSweden$1.59B+28%+11%9%15.2×1.1%+7.7%
GeneDx WGSUnited States$1.56B+16%+15%-14%54.2×n/an/a
BillionToOne BLLNUnited States$4.37B+7%+72%10%115.3×22.8%+71.9%

Questions

Who are Meinian Onehealth Healthcare's main competitors?
Named competitors: iKang Healthcare (private or unlisted). The cockpit's measured peer set (industry) also includes Pediatrix Medical (MD), Aveanna Healthcare (AVAH), Addus HomeCare (ADUS), AddLife (ALIF-B.ST), Azenta (AZTA), NeoGenomics (NEO).
Is Meinian Onehealth Healthcare expensive compared with its peers?
On forward p/e it trades at 49.6× against a peer median of 37.6×, 8th most expensive of 17 in its peer set. For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is -1 pp: the price already allows for a slowdown.
How has Meinian Onehealth Healthcare stock performed?
Over six months to 18 Nov 2026 the shares returned -26.6% against +19.1% for the median peer; over one year -18.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.